收缩
中文版 / 繁体版
English
Home
About us
News Centre
Products Centre
Technical Info
Recruitment
Feedback
Contact us
PRODUCTS
Nanochip Series
Bone Biomarkers
WNT Assay
Respiratory Markers
Gastrology Markers
Cardiovascular Markers
Food Assay
IVD Raw Material
Animal Models
Other Assay
● Steroid Hormones
● Thyroid Monitoring
● Growth
● Diabetes
● Quality Control
● Real Time PCR
● Genetic Assay
● Food Assay
PRODUCTS
Your current location：Home > Our Products >> Drug Level Assay
SHIKARI® Q-INFLIXI

Enzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma.

The Matriks Biotek Shikari® Infliximab-Remicade ELISA has been especially developed for the quantitative analysis of free infliximab in serum and plasma samples.


Required Volume (μl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 100
Spike Recovery (%) Between 85-115
Shelf Life (year) 1








HomeAbout usNews CentreProducts CentreRecruitmentContact us
© Copyright Beijing Rongzhi Haida Biotech Co., Ltd.
Beijing headquarters Tel:+86.10.5889.5809 +86.10.5889.5646 Fax: +86.10.5889.5611 E-mail:market@rz-biotech.com
(BJ)ICP12047214 Technical support：wanmeiweb.com